These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 8797581

  • 1. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells.
    Powell CT, Gschwend JE, Fair WR, Brittis NJ, Stec D, Huryk R.
    Cancer Res; 1996 Sep 15; 56(18):4137-41. PubMed ID: 8797581
    [Abstract] [Full Text] [Related]

  • 2. Differential expression of protein kinase C isozyme messenger RNAs in dunning R-3327 rat prostatic tumors.
    Powell CT, Fair WR, Heston WD.
    Cell Growth Differ; 1994 Feb 15; 5(2):143-9. PubMed ID: 8180127
    [Abstract] [Full Text] [Related]

  • 3. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo.
    Achbarou A, Kaiser S, Tremblay G, Ste-Marie LG, Brodt P, Goltzman D, Rabbani SA.
    Cancer Res; 1994 May 01; 54(9):2372-7. PubMed ID: 8162583
    [Abstract] [Full Text] [Related]

  • 4. The effects of gossypol on the invasiveness of MAT-LyLu cells and MAT-LyLu cells from the metastasized lungs of MAT-LyLu-bearing Copenhagen rats.
    Jiang J, Kulp SK, Sugimoto Y, Liu S, Lin YC.
    Anticancer Res; 2000 May 01; 20(6B):4591-7. PubMed ID: 11205308
    [Abstract] [Full Text] [Related]

  • 5. Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R-3327 rat prostatic adenocarcinoma model.
    Mohler JL, Levy F, Sharief Y.
    Cancer Res; 1991 Dec 15; 51(24):6580-5. PubMed ID: 1742730
    [Abstract] [Full Text] [Related]

  • 6. (-)-Gossypol reduces invasiveness in metastatic prostate cancer cells.
    Huang YW, Wang LS, Dowd MK, Wan PJ, Lin YC.
    Anticancer Res; 2009 Jun 15; 29(6):2179-88. PubMed ID: 19528479
    [Abstract] [Full Text] [Related]

  • 7. The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor.
    Isaacs JT, Yu GW, Coffey DS.
    Invest Urol; 1981 Jul 15; 19(1):20-3. PubMed ID: 7251319
    [Abstract] [Full Text] [Related]

  • 8. Transfected neu oncogene induces human prostate cancer metastasis.
    Zhau HY, Zhou J, Symmans WF, Chen BQ, Chang SM, Sikes RA, Chung LW.
    Prostate; 1996 Feb 15; 28(2):73-83. PubMed ID: 8604395
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, Binderup L.
    Cancer Epidemiol Biomarkers Prev; 1999 Mar 15; 8(3):241-8. PubMed ID: 10090302
    [Abstract] [Full Text] [Related]

  • 10. The effect of castanospermine on the metastatic properties of prostate cancer cells.
    Yee CS, Schwab ED, Lehr JE, Quigley M, Pienta KJ.
    Anticancer Res; 1997 Mar 15; 17(5A):3659-63. PubMed ID: 9413219
    [Abstract] [Full Text] [Related]

  • 11. Protein Kinase-zeta inhibits collagen I-dependent and anchorage-independent growth and enhances apoptosis of human Caco-2 cells.
    Mustafi R, Cerda S, Chumsangsri A, Fichera A, Bissonnette M.
    Mol Cancer Res; 2006 Sep 15; 4(9):683-94. PubMed ID: 16940160
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade.
    Evans CP, Elfman F, Parangi S, Conn M, Cunha G, Shuman MA.
    Cancer Res; 1997 Aug 15; 57(16):3594-9. PubMed ID: 9270033
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
    Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2000 May 15; 6(5):2104-19. PubMed ID: 10815938
    [Abstract] [Full Text] [Related]

  • 15. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
    Chang CJ, Ghosh PK, Hu YF, Brueggemeier RW, Lin YC.
    Res Commun Chem Pathol Pharmacol; 1993 Mar 15; 79(3):293-312. PubMed ID: 8480076
    [Abstract] [Full Text] [Related]

  • 16. Fibroblast growth factor-2 and TPA enhance prostate-cancer-cell proliferation and activate members of the Ras and PKC signal transduction pathways.
    Hrzenjak M, Shain SA.
    Recept Signal Transduct; 1997 Mar 15; 7(4):207-19. PubMed ID: 9633822
    [Abstract] [Full Text] [Related]

  • 17. Zeta isoform of protein kinase C prevents oxidant-induced nuclear factor-kappaB activation and I-kappaBalpha degradation: a fundamental mechanism for epidermal growth factor protection of the microtubule cytoskeleton and intestinal barrier integrity.
    Banan A, Fields JZ, Zhang LJ, Shaikh M, Farhadi A, Keshavarzian A.
    J Pharmacol Exp Ther; 2003 Oct 15; 307(1):53-66. PubMed ID: 12893839
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Overexpression of human tumor metastasis-related gene TMSG-1 suppresses cell proliferation and invasion of a highly metastatic prostate cancer cell line PC-3M-1E8 in vitro].
    Su J, You JF, Wang JL, Cui XL, Fang WG, Zheng J.
    Zhonghua Zhong Liu Za Zhi; 2008 Jun 15; 30(6):404-7. PubMed ID: 19024511
    [Abstract] [Full Text] [Related]

  • 20. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
    Rabbani SA, Gladu J.
    Cancer Res; 2002 Apr 15; 62(8):2390-7. PubMed ID: 11956102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.